BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nabirotchkin S, Peluffo AE, Rinaudo P, Yu J, Hajj R, Cohen D. Next-generation drug repurposing using human genetics and network biology. Curr Opin Pharmacol 2020;51:78-92. [PMID: 31982325 DOI: 10.1016/j.coph.2019.12.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 21.5] [Reference Citation Analysis]
Number Citing Articles
1 Cross B, Turner R, Pirmohamed M. Polygenic risk scores: An overview from bench to bedside for personalised medicine. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1000667] [Reference Citation Analysis]
2 Koch E, Demontis D. Drug repurposing candidates to treat core symptoms in autism spectrum disorder. Front Pharmacol 2022;13:995439. [DOI: 10.3389/fphar.2022.995439] [Reference Citation Analysis]
3 Koch E, Kauppi K, Chen CH. Candidates for drug repurposing to address the cognitive symptoms in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2022;:110637. [PMID: 36099967 DOI: 10.1016/j.pnpbp.2022.110637] [Reference Citation Analysis]
4 Gupta C, Xu J, Jin T, Khullar S, Liu X, Alatkar S, Cheng F, Wang D. Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer’s disease. PLoS Comput Biol 2022;18:e1010287. [DOI: 10.1371/journal.pcbi.1010287] [Reference Citation Analysis]
5 Reddy DS, Sinha A, Kumar A, Saini VK. Drug re-engineering and repurposing: A significant and rapid approach to tuberculosis drug discovery. Arch Pharm (Weinheim) 2022;:e2200214. [PMID: 35841594 DOI: 10.1002/ardp.202200214] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Inci N, Kamali D, Akyildiz EO, Tahir Turanli E, Bozaykut P. Translation of Cellular Senescence to Novel Therapeutics: Insights From Alternative Tools and Models. Front Aging 2022;3. [DOI: 10.3389/fragi.2022.828058] [Reference Citation Analysis]
7 de Souza JG, Fernandes MAC, de Melo Barbosa R. A Novel Deep Neural Network Technique for Drug–Target Interaction. Pharmaceutics 2022;14:625. [DOI: 10.3390/pharmaceutics14030625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Koch E, Kauppi K, Chen C. Candidates for Drug Repurposing to Address the Cognitive Symptoms in Schizophrenia.. [DOI: 10.1101/2022.03.07.483231] [Reference Citation Analysis]
9 Trenfield SJ, Awad A, McCoubrey LE, Elbadawi M, Goyanes A, Gaisford S, Basit AW. Advancing pharmacy and healthcare with virtual digital technologies. Adv Drug Deliv Rev 2022;182:114098. [PMID: 34998901 DOI: 10.1016/j.addr.2021.114098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Chavda VP, Kapadia C, Soni S, Prajapati R, Chauhan SC, Yallapu MM, Apostolopoulos V. A global picture: therapeutic perspectives for COVID-19. Immunotherapy. [DOI: 10.2217/imt-2021-0168] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]
11 Liang S, Liu H, Liu D, Lv W, Wang S, Liu J, Greenbaum J, Shen H, Xiao H, Deng H. Network-Based Approach to Repurpose Approved Drugs for COVID-19 by Integrating GWAS and Text Mining Data. Processes 2022;10:326. [DOI: 10.3390/pr10020326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Singla RK, Joon S, Shen L, Shen B. Translational Informatics for Natural Products as Antidepressant Agents. Front Cell Dev Biol 2022;9:738838. [DOI: 10.3389/fcell.2021.738838] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Gupta C, Xu J, Jin T, Khullar S, Liu X, Alatkar S, Cheng F, Wang D. Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer’s disease.. [DOI: 10.1101/2022.01.09.475548] [Reference Citation Analysis]
14 Kumar S. In Silico Drug Repositioning for COVID-19: Progress and Challenges. Frontiers of COVID-19 2022. [DOI: 10.1007/978-3-031-08045-6_24] [Reference Citation Analysis]
15 Al Rawi Y, Malik SS, Masood N. Chemotolerance of Breast Cancer and Its Management by Personalized Medicine. Breast Cancer: From Bench to Personalized Medicine 2022. [DOI: 10.1007/978-981-19-0197-3_16] [Reference Citation Analysis]
16 Olla S, Steri M, Formato A, Whalen MB, Corbisiero S, Agresti C. Combining Human Genetics of Multiple Sclerosis with Oxidative Stress Phenotype for Drug Repositioning. Pharmaceutics 2021;13:2064. [PMID: 34959343 DOI: 10.3390/pharmaceutics13122064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Buphamalai P, Kokotovic T, Nagy V, Menche J. Network analysis reveals rare disease signatures across multiple levels of biological organization. Nat Commun 2021;12:6306. [PMID: 34753928 DOI: 10.1038/s41467-021-26674-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
18 Rivero-García I, Castresana-Aguirre M, Guglielmo L, Guala D, Sonnhammer ELL. Drug repurposing improves disease targeting 11-fold and can be augmented by network module targeting, applied to COVID-19. Sci Rep 2021;11:20687. [PMID: 34667255 DOI: 10.1038/s41598-021-99721-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Chen SD, Yang JL, Hsieh YH, Lin TK, Lin YC, Chao AC, Yang DI. Potential Roles of Sestrin2 in Alzheimer's Disease: Antioxidation, Autophagy Promotion, and Beyond. Biomedicines 2021;9:1308. [PMID: 34680426 DOI: 10.3390/biomedicines9101308] [Reference Citation Analysis]
20 Yao S, Chen Z, Yu Y, Zhang N, Jiang H, Zhang G, Zhang Z, Zhang B. Current Pharmacological Strategies for Duchenne Muscular Dystrophy. Front Cell Dev Biol 2021;9:689533. [PMID: 34490244 DOI: 10.3389/fcell.2021.689533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
21 Carrasquilla GD, Christiansen MR, Kilpeläinen TO. The Genetic Basis of Hypertriglyceridemia. Curr Atheroscler Rep 2021;23:39. [PMID: 34146174 DOI: 10.1007/s11883-021-00939-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
22 Cantrell MS, Soto-Avellaneda A, Wall JD, Ajeti AD, Morrison BE, Warner LR, McDougal OM. Repurposing Drugs to Treat Heart and Brain Illness. Pharmaceuticals (Basel) 2021;14:573. [PMID: 34208502 DOI: 10.3390/ph14060573] [Reference Citation Analysis]
23 Lucchetta M, Pellegrini M. Drug Repositioning by Merging Active Subnetworks Validated in Cancer and COVID-19.. [DOI: 10.1101/2021.05.13.21257140] [Reference Citation Analysis]
24 Heilbron K, Mozaffari SV, Vacic V, Yue P, Wang W, Shi J, Jubb AM, Pitts SJ, Wang X. Advancing drug discovery using the power of the human genome. J Pathol 2021;254:418-29. [PMID: 33748968 DOI: 10.1002/path.5664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Lombardo SD, Basile MS, Ciurleo R, Bramanti A, Arcidiacono A, Mangano K, Bramanti P, Nicoletti F, Fagone P. A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy. Genes (Basel) 2021;12:543. [PMID: 33918694 DOI: 10.3390/genes12040543] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Li X, Yu J, Zhang Z, Ren J, Peluffo AE, Zhang W, Zhao Y, Wu J, Yan K, Cohen D, Wang W. Network bioinformatics analysis provides insight into drug repurposing for COVID-19. Med Drug Discov 2021;10:100090. [PMID: 33817623 DOI: 10.1016/j.medidd.2021.100090] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 23.0] [Reference Citation Analysis]
27 Vargas RJ, Cobar OM. The Urgent Need for Management of Biological Samples and Data Accessibility in Latin America. Front Pharmacol 2021;12:620043. [PMID: 33867983 DOI: 10.3389/fphar.2021.620043] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Singh K, Fang H, Davies G, Wright B, Lockstone H, Williams RO, Ciháková D, Knight JC, Bhattacharya S. Transcriptomic Analysis of Inflammatory Cardiomyopathy Identifies Molecular Signatures of Disease and Informs in silico Prediction of a Network-Based Rationale for Therapy. Front Immunol 2021;12:640837. [PMID: 33746983 DOI: 10.3389/fimmu.2021.640837] [Reference Citation Analysis]
29 Grahl MVC, Alcará AM, Perin APA, Moro CF, Pinto ÉSM, Feltes BC, Ghilardi IM, Rodrigues FVF, Dorn M, da Costa JC, Norberto de Souza O, Ligabue-Braun R. Evaluation of drug repositioning by molecular docking of pharmaceutical resources available in the Brazilian healthcare system against SARS-CoV-2. Inform Med Unlocked 2021;23:100539. [PMID: 33623816 DOI: 10.1016/j.imu.2021.100539] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
30 Moingeon P. [Applications of artificial intelligence to new drug development]. Ann Pharm Fr 2021;79:566-71. [PMID: 33529579 DOI: 10.1016/j.pharma.2021.01.008] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Peña‐guerrero J, Nguewa PA, García‐sosa AT. Machine learning, artificial intelligence, and data science breaking into drug design and neglected diseases. WIREs Comput Mol Sci 2021;11. [DOI: 10.1002/wcms.1513] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
32 Poduri R. Historical Perspective of Drug Discovery and Development. Drug Discovery and Development 2021. [DOI: 10.1007/978-981-15-5534-3_1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Sharma S, Prakash A, Sarma P, Medhi B. Machine Learning Techniques for Development of Drugs Against Coronavirus Disease 2019 (COVID-19): A Case Study Protocol. Methods in Pharmacology and Toxicology 2021. [DOI: 10.1007/7653_2020_70] [Reference Citation Analysis]
34 Kwok AJ, Mentzer A, Knight JC. Host genetics and infectious disease: new tools, insights and translational opportunities. Nat Rev Genet 2021;22:137-53. [PMID: 33277640 DOI: 10.1038/s41576-020-00297-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 24.5] [Reference Citation Analysis]
35 Kumar N, Mishra B, Mehmood A, Mohammad Athar, M Shahid Mukhtar. Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis. iScience 2020;23:101526. [PMID: 32895641 DOI: 10.1016/j.isci.2020.101526] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 16.0] [Reference Citation Analysis]
36 Nilbert M, Mellemkjær L. Drug repositioning in cancer: a role for antihistamines in breast cancer? Acta Oncol 2020;59:1007-8. [PMID: 32811253 DOI: 10.1080/0284186X.2020.1808240] [Reference Citation Analysis]
37 Gates LE, Hamed AA. The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation. J Med Internet Res 2020;22:e21169. [PMID: 32735546 DOI: 10.2196/21169] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
38 Chellapandi P, Saranya S. Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery. Med Chem Res 2020;:1-15. [PMID: 32837137 DOI: 10.1007/s00044-020-02610-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
39 Saxena A. Drug targets for COVID-19 therapeutics: Ongoing global efforts. J Biosci 2020;45:87. [PMID: 32661214 [PMID: 32661214 DOI: 10.1007/s12038-020-00067-w] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 27.0] [Reference Citation Analysis]
40 Lau A, So HC. Turning genome-wide association study findings into opportunities for drug repositioning. Comput Struct Biotechnol J 2020;18:1639-50. [PMID: 32670504 DOI: 10.1016/j.csbj.2020.06.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
41 Gates LE, Hamed AA. The Anatomy of SARS-CoV-2 BioMedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation (Preprint).. [DOI: 10.2196/preprints.21169] [Reference Citation Analysis]
42 Kumar N, Mishra B, Mehmood A, Athar M, Mukhtar MS. Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis. SSRN 2020;:3581857. [PMID: 32714115 DOI: 10.2139/ssrn.3581857] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
43 Kumar N, Mishra B, Mehmood A, Athar M, Mukhtar MS. Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis.. [DOI: 10.1101/2020.04.09.033910] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]